Literature DB >> 6177980

Lewis blood-type may affect the incidence of gastrointestinal cancer.

H Koprowski, M Brockhaus, M Blaszczyk, J Magnani, Z Steplewski, V Ginsburg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177980     DOI: 10.1016/s0140-6736(82)92402-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  20 in total

1.  ABO blood groups and cancer of the pancreas.

Authors:  V Annese; M Minervini; A Gabbrielli; G Gambassi; R Manna
Journal:  Int J Pancreatol       Date:  1990-03

Review 2.  Molecular markers of pancreatic cancer: development and clinical relevance.

Authors:  Lucia C Fry; Klaus Mönkemüller; Peter Malfertheiner
Journal:  Langenbecks Arch Surg       Date:  2008-02-12       Impact factor: 3.445

3.  CA 19-9 serum course and prognosis of pancreatic cancer.

Authors:  F Safi; W Schlosser; S Falkenreck; H G Beger
Journal:  Int J Pancreatol       Date:  1996-12

4.  Presence of two distinct acinar cell populations in human pancreas based on their antigenicity.

Authors:  E Uchida; Z Steplewski; E Mroczek; M Büchler; D Burnett; P M Pour
Journal:  Int J Pancreatol       Date:  1986-10

5.  Blood-group antigen expression during pancreatic cancer induction in hamsters.

Authors:  P M Pour; E Uchida; D A Burnett; Z Steplewski
Journal:  Int J Pancreatol       Date:  1986-12

6.  Comparative studies on expression of CA 19-9 and DU-PAN-2 in pancreatic cancer tissue.

Authors:  H Takasaki; E Uchida; M A Tempero; D A Burnett; R S Metzgar; P M Pour
Journal:  Int J Pancreatol       Date:  1987 Oct-Dec

7.  Serological and immunohistochemical studies on sialylated carbohydrate antigens in colorectal carcinoma.

Authors:  T Nakagoe; H Kusano; M Hirota; K Fukushima; K Hiratani; K Hara; M Tomita
Journal:  Gastroenterol Jpn       Date:  1991-06

8.  Diagnostic value of CA 19-9 in patients with pancreatic cancer and nonspecific gastrointestinal symptoms.

Authors:  F Safi; W Schlosser; G Kolb; H G Beger
Journal:  J Gastrointest Surg       Date:  1997 Mar-Apr       Impact factor: 3.452

9.  Evaluation of CEA, CA 19-9, CA-50, CA-195, and TATI with special reference to pancreatic disorders.

Authors:  P Masson; B Pålsson; A Andren-Sandberg
Journal:  Int J Pancreatol       Date:  1991-05

10.  Factors affecting serum levels of CA 19-9 with special reference to benign hepatobiliary and pancreatic diseases.

Authors:  N Sawabu; Y Takemori; D Toya; M Yoneshima; H Kidani; Y Satomura; H Ohta; N Hattori
Journal:  Gastroenterol Jpn       Date:  1986-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.